Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Mecillinam for Treatment of Genital Chlamydia Infection in Asymptomatic Men

NCT02083276 is registered in ClinicalTrials.gov with Oslo University Hospital as lead sponsor.

NCT NCT02083276
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02083276 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Mecillinam for Treatment of Genital Chlamydia Infection in Asymptomatic Men
Lead sponsor
Oslo University Hospital
Phase
Phase 2
Overall status
Terminated
Start date
March 31, 2014
Completion date
May 31, 2015
Enrollment
20 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

chlamydia trachomatis infection, chlamydial urethritis